IL137253A0 - Compositions and methods for modulating cytokine release in response to genotoxic agents - Google Patents

Compositions and methods for modulating cytokine release in response to genotoxic agents

Info

Publication number
IL137253A0
IL137253A0 IL13725399A IL13725399A IL137253A0 IL 137253 A0 IL137253 A0 IL 137253A0 IL 13725399 A IL13725399 A IL 13725399A IL 13725399 A IL13725399 A IL 13725399A IL 137253 A0 IL137253 A0 IL 137253A0
Authority
IL
Israel
Prior art keywords
compositions
response
methods
cytokine release
genotoxic agents
Prior art date
Application number
IL13725399A
Other languages
English (en)
Original Assignee
Applied Genetics Inc Dermatics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Genetics Inc Dermatics filed Critical Applied Genetics Inc Dermatics
Publication of IL137253A0 publication Critical patent/IL137253A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13725399A 1998-02-04 1999-02-04 Compositions and methods for modulating cytokine release in response to genotoxic agents IL137253A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7364098P 1998-02-04 1998-02-04
PCT/US1999/002348 WO1999039720A1 (en) 1998-02-04 1999-02-04 Compositions and methods for modulating cytokine release in response to genotoxic agents

Publications (1)

Publication Number Publication Date
IL137253A0 true IL137253A0 (en) 2001-07-24

Family

ID=22114913

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13725399A IL137253A0 (en) 1998-02-04 1999-02-04 Compositions and methods for modulating cytokine release in response to genotoxic agents

Country Status (7)

Country Link
EP (1) EP1052998A4 (de)
JP (1) JP2002502820A (de)
CN (1) CN1296413A (de)
AU (1) AU2494499A (de)
CA (1) CA2319567A1 (de)
IL (1) IL137253A0 (de)
WO (1) WO1999039720A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG43072A1 (en) * 1991-06-18 1997-10-17 American Home Prod Method of treating adult t-cell leukemia/lymphoma

Also Published As

Publication number Publication date
EP1052998A1 (de) 2000-11-22
JP2002502820A (ja) 2002-01-29
AU2494499A (en) 1999-08-23
CN1296413A (zh) 2001-05-23
CA2319567A1 (en) 1999-08-12
WO1999039720A1 (en) 1999-08-12
EP1052998A4 (de) 2003-02-26

Similar Documents

Publication Publication Date Title
HUP0104943A2 (en) Controlled release formulation comprising gnrh-ii and its use
EP1176948A4 (de) Anti-nausea zusammensetzungen und methoden
GB9813271D0 (en) Composition and use
HUP0103562A3 (en) Novel compositions and use
EP1056456A4 (de) R-lansoprazol zusammenstellungen und behandlungen damit
HK1033653A1 (en) Synergistic composition and use thereof
IL144710A0 (en) Methods and compositions for use in perfusion applications
AU5073101A (en) Lipid composition and use thereof
EP0980202A4 (de) Verfahren zur viralen inaktivierung und darin verwendbare zusammensetzungen
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
EP1073333A4 (de) S-rabeprazol enthaltende zusammensetzungen und verfahren
EP1075184A4 (de) Zusammensetzungen und verfahren zur aktiven impfung
GB9725946D0 (en) Lipid compositions and their use
IL147645A0 (en) Rest-breaking composition and use thereof
EP1032544A4 (de) Zusammensetzungen der verwendung in beton und die damit erzeugten betongegenstände
IL137253A0 (en) Compositions and methods for modulating cytokine release in response to genotoxic agents
PL339808A1 (en) Alkoxylated amined and their application in cleaning compositions
GB9815798D0 (en) Improvements in and relating to casting
GB9606549D0 (en) Improvements in or relating to load spreading plates
GB9911606D0 (en) Composition and use
ZA983205B (en) Sustained release compositions and the process for their preparation
GB9703408D0 (en) Improvements in and relating to beverage forming compositions
GB9719318D0 (en) Improvements in and relating to casting
GB9805172D0 (en) Composition and use
GB9722392D0 (en) Composition and use